Absorption |
Blood-Brain Barrier | BBB+ | 0.8771 |
Human Intestinal Absorption | HIA+ | 0.9773 |
Caco-2 Permeability | Caco2+ | 0.9204 |
P-glycoprotein Substrate | Substrate | 0.5103 |
P-glycoprotein Inhibitor | Inhibitor | 0.6767 |
Inhibitor | 0.5493 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8719 |
Distribution |
Subcellular localization | Mitochondria | 0.5670 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8049 |
CYP450 2D6 Substrate | Non-substrate | 0.8645 |
CYP450 3A4 Substrate | Non-substrate | 0.5536 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9766 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8339 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9083 |
CYP450 2C19 Inhibitor | Inhibitor | 0.5821 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.5902 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6391 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9704 |
Non-inhibitor | 0.9322 |
AMES Toxicity | Non AMES toxic | 0.6865 |
Carcinogens | Non-carcinogens | 0.9409 |
Fish Toxicity | High FHMT | 0.8804 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9317 |
Honey Bee Toxicity | High HBT | 0.8032 |
Biodegradation | Not ready biodegradable | 0.5460 |
Acute Oral Toxicity | II | 0.7448 |
Carcinogenicity (Three-class) | Non-required | 0.5973 |